Non-Covered
General payments
$1,237,563
Research payments
$97,137,878
Through program year 2021, $1,237,563 in general payments and $97,137,878 in research payments were reported against Non-Covered.
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | General | $532,413 | 327 |
| 2021 | Research | $29,574,257 | 5,051 |
| 2020 | General | $684,146 | 383 |
| 2020 | Research | $30,483,544 | 9,740 |
| 2019 | General | $21,004 | 24 |
| 2019 | Research | $37,080,077 | 13,255 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.
The top 5 of 36 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.
The top 5 of 31 states; each share is of general payments naming this product in 2021 where a state was reported.
Records
734 general · 28,046 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.